1932

Abstract

As with past pandemics of influenza, COVID-19 tore through US prisons and jails; however, the COVID-19 pandemic, uniquely, has led to more health research on carceral systems than has been seen to date. Herein, we review the data on its impact on incarcerated people, correctional officers, health systems, and surrounding communities. We searched medical, sociological, and criminology databases from March 2020 through February 2022 for studies examining the intersection of COVID-19, prisons and jails, and health outcomes, including COVID-19 incidence, prevalence, hospitalizations, and vaccination. Our scoping review identified 77 studies—the bulk of which focus on disease epidemiology in carceral systems, with a small minority that focuses on the efficacy or effectiveness of prevention and mitigation efforts, including testing, vaccination, and efforts to depopulate correctional facilities. We highlight areas for future research, including the experiences of incarcerated people and correctional staff, unanticipated health effects of prolonged quarantine, excess deaths due to delays in healthcare, and experimental studies on vaccine uptake and testing in correctional staff. These studies will enable a fuller understanding of COVID-19 and help stem future pandemics.

Loading

Article metrics loading...

/content/journals/10.1146/annurev-criminol-030521-103146
2023-01-27
2024-06-13
Loading full text...

Full text loading...

/deliver/fulltext/criminol/6/1/annurev-criminol-030521-103146.html?itemId=/content/journals/10.1146/annurev-criminol-030521-103146&mimeType=html&fmt=ahah

Literature Cited

  1. Abdalbary M, Kakani E, Ahmed Y, Shea M, Neyra JA, El-Husseini A. 2022. Characteristics and outcomes of prisoners hospitalized due to COVID-19 disease. Clin. Nephrol. 97:4232–41
    [Google Scholar]
  2. Altibi AM, Pallavi B, Liaqat H, Slota AA, Sheth R et al. 2021. Characteristics and comparative clinical outcomes of prisoner versus non-prisoner populations hospitalized with COVID-19. Sci. Rep. 11:6488
    [Google Scholar]
  3. Arksey H, O'Malley L 2005. Scoping studies: towards a methodological framework. Int. J. Soc. Res. Methodol. 8:19–32
    [Google Scholar]
  4. Bandara S, Kennedy-Hendricks A, Merritt S, Barry CL, Saloner B. 2020. Early effects of COVID-19 on programs providing medications for opioid use disorder in jails and prisons. J. Addict. Med. 14:E257–60
    [Google Scholar]
  5. Barrenger SL, Bond L. 2021. Mental health and service impacts during COVID-19 for individuals with serious mental illnesses recently released from prison and jail. J. Behav. Health Serv. Res. 48:610–16
    [Google Scholar]
  6. Beaudry G, Zhong S, Whiting D, Javid B, Frater J, Fazel S. 2020. Managing outbreaks of highly contagious diseases in prisons: a systematic review. BMJ Glob. Health 5:e003201
    [Google Scholar]
  7. Belcher AM, Coble K, Cole TO, Welsh CJ, Whitney A, Weintraub E 2021. Buprenorphine induction in a rural Maryland detention center during COVID-19: implementation and preliminary outcomes of a novel telemedicine treatment program for incarcerated individuals with opioid use disorder. Front. Psychiatry 12:703685
    [Google Scholar]
  8. Berk J, Murphy M, Kane K, Chan P, Rich J, Brinkley-Rubinstein L. 2021. Initial SARS-CoV-2 vaccination uptake in a correctional setting: cross-sectional study. JMIRx Med. 2:3e30176
    [Google Scholar]
  9. Brinkley-Rubinstein L, LeMasters K, Nguyen P, Nowotny K, Cloud D, Volfovsky A 2021a. The association between intersystem prison transfers and COVID-19 incidence in a state prison system. PLOS ONE 16:8e0256285
    [Google Scholar]
  10. Brinkley-Rubinstein L, Peterson M, Martin R, Chan P, Berk J. 2021b. Breakthrough SARS-CoV-2 infections in prison after vaccination. N. Engl. J. Med. 385:1051–52
    [Google Scholar]
  11. Cavanagh C, Clough I, Thomas AG. 2021. Concerns about the COVID-19 pandemic among justice-involved and low-income youth. Juv. Fam. Court J. 72:5–30
    [Google Scholar]
  12. Chan J, Burke K, Bedard R, Grigg J, Winters J et al. 2021. COVID-19 in the New York City jail system: epidemiology and health care response, March-April 2020. Public Health Rep. 136:375–83
    [Google Scholar]
  13. Cheng A, Badolato R, Segoshi A, McDonald R, Malone M et al. 2022. Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study. Addict. Sci. Clin. Pract. 17:4
    [Google Scholar]
  14. Chidavaenzi NZ, Agathis N, Lees Y, Stevens H, Clark J et al. 2022. Implementation of a COVID-19 screening testing program in a rural, tribal nation: experience of the San Carlos Apache tribe, January–February 2021. Public Health Rep. 137:220–25
    [Google Scholar]
  15. Chin ET, Leidner D, Ryckman T, Liu YRE, Prince L et al. 2021a. Covid-19 vaccine acceptance in California state prisons. N. Engl. J. Med. 385:374–76
    [Google Scholar]
  16. Chin ET, Leidner D, Zhang Y, Long E, Prince L et al. 2021b. Effectiveness of the mRNA-1273 vaccine during a SARS-CoV-2 delta outbreak in a prison. N. Engl. J. Med. 385:2300–1
    [Google Scholar]
  17. Chin ET, Leidner D, Zhang YF, Long E, Prince L et al. 2022. Effectiveness of coronavirus disease 2019 (COVID-19) vaccines among incarcerated people in California state prisons: retrospective cohort study. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciab1032
    [Crossref] [Google Scholar]
  18. Chin ET, Ryckman T, Prince L, Leidner D, Alarid-Escudero F et al. 2021c. COVID-19 in the California state prison system: an observational study of decarceration, ongoing risks, and risk factors. J. Gen. Intern. Med. 36:3096–102
    [Google Scholar]
  19. Dadiomov D, Trotzky-Sirr R, Shooshtari A, Qato DM. 2022. Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemic. Drug Alcohol Depend. 232:109291
    [Google Scholar]
  20. Davlantes E, Toro M, Villalobos R, Sanchez-Gonzalez L. 2020. Notes from the field: COVID-19 prevention practices in state prisons—Puerto Rico, 2020. Morb. Mortal. Wkly. Rep. 69:1144
    [Google Scholar]
  21. Denney MGT, Valdez RG. 2021. Compounding racialized vulnerability: COVID-19 in prisons, jails, and migrant detention centers. J. Health Politics Policy Law 46:861–87
    [Google Scholar]
  22. DePalma A, Noujaim D, Coman E, Wakefield D, Barry LC 2022. Older incarcerated persons’ mental health before and during the COVID-19 pandemic. Int. J. Prison Health 18:213848
    [Google Scholar]
  23. Duncan A, Sanders N, Schiff M, Winkelman TNA. 2021. Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic. J. Subst. Abuse Treat. 121:108161
    [Google Scholar]
  24. Dunne EM, Morgan E, Wells-Moore B, Pierson S, Zakroff S et al. 2021. COVID-19 outbreaks in correctional facilities with work-release programs—Idaho, July–November 2020. Morb. Mortal. Wkly. Rep. 70:589–94
    [Google Scholar]
  25. Engel L, Abaroa-Ellison J, Jemison E, Cumberbatch K 2020. Racial disparities and COVID-19 Rep., Natl. Comm. COVID-19 Crim. Justice Washington, DC: https://build.neoninspire.com/counciloncj/wp-content/uploads/sites/96/2021/07/Racial-Disparities-and-COVID-19-Report.pdf
    [Google Scholar]
  26. Enns PK, Yi Y, Comfort M, Goldman AW, Lee H et al. 2019. What percentage of Americans have ever had a family member incarcerated?: Evidence from the Family History of Incarceration Survey (FamHIS). Socius 5:2378023119829332
    [Google Scholar]
  27. Epting ME, Pluznik JA, Levano SR, Hua XY, Fung ICH et al. 2021. Aiming for zero: reducing transmission of coronavirus disease 2019 in the DC Department of Corrections. Open Forum Infect. Dis. 8:12ofab547
    [Google Scholar]
  28. Geana MV, Anderson S, Ramaswamy M 2021. COVID-19 vaccine hesitancy among women leaving jails: a qualitative study. Public Health Nurs. 38:892–96
    [Google Scholar]
  29. Gibson B. 2020. NCCHC survey yields insights into COVID-19 in US correctional facilities. J. Correct. Health Care 26:204–6
    [Google Scholar]
  30. Grubesic TH, Nelson JR, Wallace D, Eason J, Towers S, Walker J. 2021. Geodemographic insights on the COVID-19 pandemic in the State of Wisconsin and the role of risky facilities. GeoJournal. https://doi.org/10.1007/s10708-021-10503-5
    [Crossref] [Google Scholar]
  31. Gutierrez C, Patterson EJ. 2021. Risk and implications of COVID-19 among the community supervised population. Criminol. Public Policy 20:437–61
    [Google Scholar]
  32. Hagan LM, Dusseau C, Crockett M, Rodriguez T, Long MJ. 2021a. COVID-19 vaccination in the Federal Bureau of Prisons, December 2020–April 2021. Vaccine 39:5883–90
    [Google Scholar]
  33. Hagan LM, McCormick DW, Lee C, Sleweon S, Nicolae L et al. 2021b. Outbreak of SARS-CoV-2 B.1.617.2 (delta) variant infections among incarcerated persons in a federal prison—Texas, July–August 2021. Morb. Mortal. Wkly. Rep. 70:1349–54
    [Google Scholar]
  34. Hagan LM, Williams SP, Spaulding AC, Toblin RL, Figlenski J et al. 2020. Mass testing for SARS-CoV-2 in 16 prisons and jails—six jurisdictions, United States, April–May 2020. Morb. Mortal. Wkly. Rep. 69:1139–43
    [Google Scholar]
  35. Hartmann S, Rubin Z, Sato H, Yong KO, Terashita D, Balter S. 2021. Coronavirus disease 2019 (COVID-19) infections among healthcare workers, Los Angeles County, February–May 2020. Clin. Infect. Dis. 73:E1850–54
    [Google Scholar]
  36. Hawks L, Lopoo E, Puglisi L, Cellini J, Thompson K et al. 2022. Community investment interventions as a means for decarceration: a scoping review. Lancet Reg. Health Am. 8:100150
    [Google Scholar]
  37. Heiss J, Hinds O, Schattner-Elmaleh E, Wallace-Lee J. 2020. The scale of the COVID-19-related jail population decline Rep., Vera Inst. Justice Brooklyn, NY: https://www.vera.org/publications/covid19-jail-population-decline
    [Google Scholar]
  38. Hershow RB, Segaloff HE, Shockey AC, Florek KR, Murphy SK et al. 2021. Rapid spread of SARS-CoV-2 in a state prison after introduction by newly transferred incarcerated persons—Wisconsin, August 14–October 22, 2020. Morb. Mortal. Wkly. Rep. 70:478–82
    [Google Scholar]
  39. Jimenez MC, Cowger TL, Simon LE, Behn M, Cassarino N, Bassett MT. 2020. Epidemiology of COVID-19 among incarcerated individuals and staff in Massachusetts jails and prisons. JAMA Netw. Open 3:8e20188510
    [Google Scholar]
  40. Kennedy BS, Richeson RP, Houde AJ. 2020. Risk factors for SARS-CoV-2 in a statewide correctional system. N. Engl. J. Med. 383:2479–80
    [Google Scholar]
  41. Khorasani SB, Koutoujian PJ, Zubiago J, Guardado R, Siddiqi K, Wurcel AG. 2021. COVID-19 vaccine interest among corrections officers and people who are incarcerated at Middlesex County Jail, Massachusetts. J. Urban Health 98:459–63
    [Google Scholar]
  42. Kirbiyik U, Binder AM, Ghinai I, Zawitz C, Levin R et al. 2020. Network characteristics and visualization of COVID-19 outbreak in a large detention facility in the United States—Cook County, Illinois, 2020. Morb. Mortal. Wkly. Rep. 69:1625–30
    [Google Scholar]
  43. Klein M, Kowalski MA, Woo Y, Solis C, Mendoza M et al. 2022. The novel coronavirus and enforcement of the new separate system in prisons. Crim. Justice Policy Rev. 33:206–30
    [Google Scholar]
  44. Lehnertz NB, Wang X, Garfin J, Taylor J, Zipprich J et al. 2021. Transmission dynamics of severe acute respiratory syndrome coronavirus 2 in high-density settings, Minnesota, USA, March–June 2020. Emerg. Infect. Dis. 27:2052–63
    [Google Scholar]
  45. Leibowitz AI, Siedner MJ, Tsai AC, Mohareb AM. 2021. Association between prison crowding and COVID-19 incidence rates in Massachusetts prisons, April 2020–January 2021. JAMA Intern. Med. 181:1315–21
    [Google Scholar]
  46. Lemasters K, McCauley E, Nowotny K, Brinkley-Rubinstein L 2020. COVID-19 cases and testing in 53 prison systems. Health Justice 8:24
    [Google Scholar]
  47. Levac D, Colquhoun H, O'Brien KK. 2010. Scoping studies: advancing the methodology. Implement. Sci. 5:69
    [Google Scholar]
  48. Lewis NM, Salmanson AP, Price A, Risk I, Guymon C et al. 2021. Community-associated outbreak of COVID-19 in a correctional facility—Utah, September 2020–January 2021. Morb. Mortal. Wkly. Rep. 70:467–72
    [Google Scholar]
  49. Liu YE, Oto J, Will J, LeBoa C, Doyle A et al. 2022. Factors associated with COVID-19 vaccine acceptance and hesitancy among residents of Northern California jails. Prev. Med. Rep. 27:101771
    [Google Scholar]
  50. Lorvick J, Hemberg J, Cropsey K, Wickliffe J, Faust A et al. 2020. Sources of information and health care experiences related to COVID-19 among women involved in criminal legal system in three U.S. cities. Arch. Women Health Care. https://doi.org/10.31038/awhc.2020351
    [Crossref] [Google Scholar]
  51. Malloy GSP, Puglisi L, Brandeau ML, Harvey TD, Wang EA. 2021. Effectiveness of interventions to reduce COVID-19 transmission in a large urban jail: a model-based analysis. BMJ Open 11:e042898
    [Google Scholar]
  52. Maner M, LeMasters K, Lao JN, Cowell M, Nowotny K et al. 2021. COVID-19 in corrections: quarantine of incarcerated people. PLOS ONE 16:10e0257842
    [Google Scholar]
  53. Marquez N, Ward JA, Parish K, Saloner B, Dolovich S. 2021. COVID-19 incidence and mortality in federal and state prisons compared with the US population, April 5, 2020, to April 3, 2021. JAMA 326:1865–67
    [Google Scholar]
  54. Marquez NM, Littman AM, Rossi VE, Everett MC, Tyagi E et al. 2022. Life expectancy and COVID-19 in Florida state prisons. Am. J. Prev. Med. 62:6949–52
    [Google Scholar]
  55. Marusinec R, Brodie D, Buhain S, Chawla C, Corpuz J et al. 2022. Epidemiology of coronavirus disease 2019 at a county jail—Alameda County, California, March 2020–March 2021. J. Public Health Manag. Pract. 28:50–59
    [Google Scholar]
  56. McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. 2016. PRESS peer review of electronic search strategies: 2015 guideline statement. J. Clin. Epidemiol. 75:40–46
    [Google Scholar]
  57. Miller E, Martin BD, Topaz CM. 2022. New York City jails: COVID discharge policy, data transparency, and reform. PLOS ONE 17:e0262255
    [Google Scholar]
  58. Montgomery MP, Hong K, Clarke KEN, Williams S, Fukunaga R et al. 2022. Hospitalizations for COVID-19 among US people experiencing incarceration or homelessness. JAMA Netw. Open 5:1e2143407
    [Google Scholar]
  59. Mutesa L, Ndishimye P, Butera Y, Souopgui J, Uwineza A et al. 2021. A pooled testing strategy for identifying SARS-CoV-2 at low prevalence. Nature 589:276–80
    [Google Scholar]
  60. Njuguna H, Wallace M, Simonson S, Tobolowsky FA, James AE et al. 2020. Serial laboratory testing for SARS-CoV-2 infection among incarcerated and detained persons in a correctional and detention facility—Louisiana, April–May 2020. Morb. Mortal. Wkly. Rep. 69:836–40
    [Google Scholar]
  61. Nowotny KM, Bailey Z, Brinkley-Rubinstein L. 2021a. The contribution of prisons and jails to US racial disparities during COVID-19. Am. J. Public Health 111:197–99
    [Google Scholar]
  62. Nowotny KM, Seide K, Brinkley-Rubinstein L. 2021b. Risk of COVID-19 infection among prison staff in the United States. BMC Public Health 21:1036
    [Google Scholar]
  63. Parsons TL, Worden L. 2021. Assessing the risk of cascading COVID-19 outbreaks from prison-to-prison transfers. Epidemics 37:100532
    [Google Scholar]
  64. Pettus-Davis C, Kennedy SC, Veeh CA. 2021. Incarcerated individuals’ experiences of COVID-19 in the United States. Int. J. Prison. Health 17:335–50
    [Google Scholar]
  65. Pocock K, Close R, McAuley J. 2020. The porous boundaries between communities and correctional facilities: the introduction of a medical recovery site resulting in reduced COVID-19 household transmission tied to recently incarcerated individuals. Open Forum Infect. Dis. 7:S308–9
    [Google Scholar]
  66. Pringle JC, Leikauskas J, Ransom-Kelley S, Webster B, Santos S et al. 2020. COVID-19 in a correctional facility employee following multiple brief exposures to persons with COVID-19—Vermont, July–August 2020. Morb. Mortal. Wkly. Rep. 69:1569–70
    [Google Scholar]
  67. Puglisi LB, Malloy GSP, Harvey TD, Brandeau ML, Wang EA. 2021. Estimation of COVID-19 basic reproduction ratio in a large urban jail in the United States. Ann. Epidemiol. 53:103–5
    [Google Scholar]
  68. Pyrooz DC, Labrecque RM, Tostlebe JJ, Useem B. 2020. Views on COVID-19 from inside prison: perspectives of high-security prisoners. Justice Eval. J. 3:294–306
    [Google Scholar]
  69. Quan NG, Latif H, Krsak M, Corbisiero MF, Solis J et al. 2021. Benefits of COVID-19 viral screening of formerly incarcerated individuals during community reentry. Ther. Adv. Infect. Dis. 8:2049936120985951
    [Google Scholar]
  70. Reinhart E, Chen DL. 2020. Incarceration and its disseminations: COVID-19 pandemic lessons from Chicago's Cook County jail. Health Aff. 39:1412–18
    [Google Scholar]
  71. Reinhart E, Chen DL. 2021a. Association of jail decarceration and anticontagion policies with COVID-19 case growth rates in US counties. JAMA Netw. Open 4:9e2123405
    [Google Scholar]
  72. Reinhart E, Chen DL. 2021b. Carceral-community epidemiology, structural racism, and COVID-19 disparities. PNAS 118:21e2026577118
    [Google Scholar]
  73. Ryckman T, Chin ET, Prince L, Leidner D, Long EL et al. 2021. Outbreaks of COVID-19 variants in US prisons: a mathematical modelling analysis of vaccination and reopening policies. Lancet Public Health 6:E760–70
    [Google Scholar]
  74. Saloner B, Parish K, Ward JA, DiLaura G, Dolovich S. 2020. COVID-19 cases and deaths in federal and state prisons. JAMA 324:602–3
    [Google Scholar]
  75. Sami S, Akinbami LJ, Petersen LR, Crawley A, Lukacs SL et al. 2021. Prevalence of SARS-CoV-2 antibodies in first responders and public safety personnel, New York City, New York, USA, May–July 2020. Emerg. Infect. Dis. 27:796–804
    [Google Scholar]
  76. Schneider JA, Taylor BG, Hotton AL, Lamuda PA, Ozik J et al. 2021. National variability in Americans' COVID-19 protective behaviors: Implications for vaccine roll-out. PLOS ONE 16:11e259257
    [Google Scholar]
  77. Scott LC, Aubee A, Babahaji L, Vigil K, Tims S, Aw TG. 2021. Targeted wastewater surveillance of SARS-CoV-2 on a university campus for COVID-19 outbreak detection and mitigation. Environ. Res. 200:111374
    [Google Scholar]
  78. Sims KM, Foltz J, Skidmore ME. 2021. Prisons and COVID-19 spread in the United States. Am. J. Public Health 111:1534–41
    [Google Scholar]
  79. Stern MF, Piasecki AM, Strick LB, Rajeshwar P, Tyagi E et al. 2021. Willingness to receive a COVID-19 vaccination among incarcerated or detained persons in correctional and detention facilities—four states, September–December 2020. Morb. Mortal. Wkly. Rep. 70:473–77
    [Google Scholar]
  80. Stokes AC, Lundberg DJ, Elo IT, Hempstead K, Bor J, Preston SH. 2021. COVID-19 and excess mortality in the United States: a county-level analysis. PLOS Med. 18:e1003571
    [Google Scholar]
  81. Strodel R, Dayton L, Garrison-Desany HM, Eber G, Beyrer C et al. 2021. COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: an analysis of state plans. PLOS ONE 16:6e0253208
    [Google Scholar]
  82. Tan SB, deSouza P, Raifman M 2022. Structural racism and COVID-19 in the USA: a county-level empirical analysis. J. Racial Ethn. Health Disparities 9:236–46
    [Google Scholar]
  83. Terebuh PD, Egwiekhor AJ, Gullett HL, Fakolade AO, Miracle JE et al. 2021. Characterization of community-wide transmission of SARS-CoV-2 in congregate living settings and local public health-coordinated response during the initial phase of the COVID-19 pandemic. Influenza Other Respiratory Viruses 15:439–45
    [Google Scholar]
  84. Testa A, Fahmy C 2021. Family member incarceration and coping strategies during the COVID-19 pandemic. Health Justice 9:16
    [Google Scholar]
  85. Toblin RL, Cohen SI, Hagan LM. 2021. SARS-CoV-2 infection among correctional staff in the Federal Bureau of Prisons. Am. J. Public Health 111:1164–67
    [Google Scholar]
  86. Toblin RL, Hagan LM. 2021. COVID-19 case and mortality rates in the Federal Bureau of Prisons. Am. J. Prev. Med. 61:120–23
    [Google Scholar]
  87. Tompkins LK, Gunn JKL, Cherney B, Ham JE, Horth R et al. 2021. Mass SARS-CoV-2 testing in a dormitory-style correctional facility in Arkansas. Am. J. Public Health 111:907–16
    [Google Scholar]
  88. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H et al. 2018. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann. Intern. Med. 169:467–73
    [Google Scholar]
  89. Vest N, Johnson O, Nowotny K, Brinkley-Rubinstein L. 2021. Prison population reductions and COVID-19: a latent profile analysis synthesizing recent evidence from the Texas state prison system. J. Urban Health 98:53–58
    [Google Scholar]
  90. Wadhwa A, Fisher KA, Silver R, Koh M, Arons MM et al. 2021. Identification of presymptomatic and asymptomatic cases using cohort-based testing approaches at a large correctional facility—Chicago, Illinois, USA, May 2020. Clin. Infect. Dis. 72:e128–35
    [Google Scholar]
  91. Wallace D, Eason JM, Walker J, Towers S, Grubesic TH, Nelson JR. 2021a. Is there a temporal relationship between COVID-19 infections among prison staff, incarcerated persons and the larger community in the United States?. Int. J. Environ. Res. Public Health 18:136873
    [Google Scholar]
  92. Wallace M, Hagan L, Curran KC, Williams SP, Handanagic S et al. 2020. COVID-19 in correctional and detention facilities—United States, February–April 2020. Morb. Mortal. Wkly. Rep. 69:587–90
    [Google Scholar]
  93. Wallace M, James AE, Silver R, Koh M, Tobolowsky FA et al. 2021b. Rapid transmission of severe acute respiratory syndrome coronavirus 2 in detention facility, Louisiana, USA, May–June, 2020. Emerg. Infect. Dis. 27:421–29
    [Google Scholar]
  94. Wang EA, Western B, Backes E, Schuck J. 2020. Decarcerating Correctional Facilities During COVID-19: Advancing Health, Equity, And Safety Washington, DC: Natl. Acad. Press
    [Google Scholar]
  95. Ward JA, Parish K, DiLaura G, Dolovich S, Saloner B. 2021. COVID-19 cases among employees of US federal and state prisons. Am. J. Prevent. Med. 60:840–44
    [Google Scholar]
  96. Zawitz C, Welbel S, Ghinai I, Mennella C, Levin R et al. 2021. Outbreak of COVID-19 and interventions in a large jail—Cook County, IL, United States, 2020. Am. J. Infect. Control 49:1129–35
    [Google Scholar]
/content/journals/10.1146/annurev-criminol-030521-103146
Loading
/content/journals/10.1146/annurev-criminol-030521-103146
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error